跳至主要内容
临床试验/NCT01457105
NCT01457105已完成不适用

PARTIALLY COVERED NITINOL "ComVi" STENT FOR PALLIATION OF MALIGNANT NON HILAR BILIARY OBSTRUCTION

Catholic University of the Sacred Heart2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2006年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
2
主要终点
patency and effectiveness of the ComVi stent in palliation of jaundice in patients with malignant biliary strictures

研究概览

简要总结

self-expandable metal stents for palliation of malignant biliary strictures

详细描述

The ComVi biliary stent (Taewoong Medical Inc., Seoul, Korea), is a covered metallic stent with a expanded polytetrafluoroethylene (e-PTFE) membrane sandwiched between two wire layers and has a weaker axial force than other stents.

Patients with middle-distal malignant biliary stricture and with symptoms as jaundice, itching and pain.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with malignant stenosis at the middle or lower third of the common bile duct inoperable and/or unresectable.
  • Patients without liver metastases and 6 months life expectancy
  • Patients at the first attempt of endoscopic biliary drainage.
  • Negative history for biliary tract surgery.

排除标准

  • Patients with ampullary cancer.
  • Patients with hilar and/or intra-hepatic ducts malignancy.
  • Patients with haemobilia.
  • Patients with acute cholangitis at the time of stenting.
  • Patients with previous percutaneous, endoscopic or surgical biliary drainage.

结局指标

主要结局

patency and effectiveness of the ComVi stent in palliation of jaundice in patients with malignant biliary strictures

时间窗: two years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Guido Costamagna

Professor

Catholic University of the Sacred Heart

研究点 (2)

Loading locations...

相似试验